Pharmacogenetic Testing Among Home Health Patients
Public ClinicalTrials.gov record NCT02378220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Prospective, Randomized Controlled Trial Assessing the Clinical Impact of Integrated Pharmacogenetic Testing on Selected OASIS Metrics, Re-hospitalizations and Emergency Department Visits
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Patients meeting eligibility criteria will be randomized into two groups, one receiving pharmacogenetic testing and the other not receiving pharmacogenetic testing. In this open-label trial, a pharmacist will make medication therapy recommendations using YouScript® Personalized Prescribing System for patients who receive genetic testing and standard drug information resources per usual for patients who do not undergo pharmacogenetic testing.
Study identification
- NCT ID
- NCT02378220
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 110 participants
Conditions and interventions
Conditions
- Adverse Drug Events
- Adverse Drug Reactions
- Drug Interaction Potentiation
- Drug Metabolism, Poor, CYP2D6-RELATED
- Drug Metabolism, Poor, CYP2C19-RELATED
- Cytochrome P450 Enzyme Deficiency
- Cytochrome P450 CYP2D6 Enzyme Deficiency
- Cytochrome P450 CYP2C9 Enzyme Deficiency
- Cytochrome P450 CYP2C19 Enzyme Deficiency
- Cytochrome P450 CYP3A Enzyme Deficiency
- Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant
- Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
- Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2015
- Primary completion
- Jan 31, 2016
- Completion
- Feb 29, 2016
- Last update posted
- Sep 19, 2019
2015 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| White County Medical Center Home Health | Searcy | Arkansas | 72143 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02378220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2019 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02378220 live on ClinicalTrials.gov.